Brief: Instil Bio Reports Q1 2023 Financial Results And Provides Corporate Update
11/05/2023 13:48
May 11 (Reuters) - Instil Bio Inc TIL.O :
* INSTIL BIO REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS
AND PROVIDES CORPORATE UPDATE
* INSTIL BIO INC - AS OF MARCH 31, 2023, INSTIL HAD CASH,
CASH
EQUIVALENTS, RESTRICTED CASH AND MARKETABLE SECURITIES OF $223.9
MILLION
* INSTIL BIO INC - CASH RUNWAY BEYOND 2026
* INSTIL BIO INC - ANTICIPATE INITIAL CLINICAL DATA FROM
ITIL-306
PHASE 1 PROGRAM IN 2024
* INSTIL BIO INC - ITIL-306 PHASE 1 STUDY ANTICIPATED TO
RECEIVE
CTA CLEARANCE FROM UK MHRA IN 2H'2023
Source text for Eikon: ID:nGNXc9xvrv
Further company coverage: TIL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Instil Bio
See all newsInstil Bio, Inc. reports results for the quarter ended June 30 - Earnings Summary
Instil Bio Q2 net loss narrows on lower R&D spending, restructuring charges
Brief: Instil Bio Q2 Basic EPS USD -0.63
Instil Bio, Inc. expected to post a loss of 43 cents a share - Earnings Preview
Instil Bio Q1 net loss narrows on lower R&D expenses